EIKN
Eikon Therapeutics, Inc. Common StockNASDAQHEALTHCAREBIOTECHNOLOGY
Key Statistics
Market Cap
$590.65M
P/E Ratio
—
EPS
$-6.32
Beta
—
52W High
$17.40
52W Low
$7.90
50-Day MA
$10.63
200-Day MA
$11.92
Dividend Yield
—
Profit Margin
0.00%
Forward P/E
—
PEG Ratio
—
About Eikon Therapeutics, Inc. Common Stock
Eikon Therapeutics, Inc., is a clinical biopharmaceutical company in the United States. The company is headquartered in Millbrae, California.
Fundamentals
| Revenue (TTM) | 0 |
| Gross Profit (TTM) | 0 |
| EBITDA | $-310.08M |
| Operating Margin | 0.00% |
| Return on Equity | -125.00% |
| Return on Assets | -36.20% |
| Revenue/Share (TTM) | $0.00 |
| Book Value | $10.17 |
| Price-to-Book | 1.07 |
| Price-to-Sales (TTM) | — |
| EV/Revenue | - |
| EV/EBITDA | — |
| Quarterly Earnings Growth (YoY) | 0.00% |
| Quarterly Revenue Growth (YoY) | 0.00% |
| Shares Outstanding | $54.14M |
| Float | $27.52M |
| % Insiders | 18.58% |
| % Institutions | 64.20% |
Historical Volatility
HV 10-Day
126.08%
HV 20-Day
110.64%
HV 30-Day
105.86%
HV 60-Day
100.62%
HV Rank
—
Volatility is currently expanding
Analyst Ratings
Consensus ($25.20 target)
2
Strong Buy3
Buy1
SellMore HEALTHCARE Stocks
Data last updated: 5/25/2026